Cargando…
Methods for analyzing cost effectiveness data from cluster randomized trials
BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Rand...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020454/ https://www.ncbi.nlm.nih.gov/pubmed/17822546 http://dx.doi.org/10.1186/1478-7547-5-12 |
_version_ | 1782136598001876992 |
---|---|
author | Bachmann, Max O Fairall, Lara Clark, Allan Mugford, Miranda |
author_facet | Bachmann, Max O Fairall, Lara Clark, Allan Mugford, Miranda |
author_sort | Bachmann, Max O |
collection | PubMed |
description | BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Randomizing clusters instead of individuals tends to increase uncertainty but such data are often analysed incorrectly in published studies. METHODS: We used data from a cluster randomized trial to demonstrate five appropriate analytic methods: 1) joint modeling of costs and effects with two-stage non-parametric bootstrap sampling of clusters then individuals, 2) joint modeling of costs and effects with Bayesian hierarchical models and 3) linear regression of net benefits at different willingness to pay levels using a) least squares regression with Huber-White robust adjustment of errors, b) a least squares hierarchical model and c) a Bayesian hierarchical model. RESULTS: All five methods produced similar results, with greater uncertainty than if cluster randomization was not accounted for. CONCLUSION: Cost effectiveness analyses alongside cluster randomized trials need to account for study design. Several theoretically coherent methods can be implemented with common statistical software. |
format | Text |
id | pubmed-2020454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20204542007-10-13 Methods for analyzing cost effectiveness data from cluster randomized trials Bachmann, Max O Fairall, Lara Clark, Allan Mugford, Miranda Cost Eff Resour Alloc Methodology BACKGROUND: Measurement of individuals' costs and outcomes in randomized trials allows uncertainty about cost effectiveness to be quantified. Uncertainty is expressed as probabilities that an intervention is cost effective, and confidence intervals of incremental cost effectiveness ratios. Randomizing clusters instead of individuals tends to increase uncertainty but such data are often analysed incorrectly in published studies. METHODS: We used data from a cluster randomized trial to demonstrate five appropriate analytic methods: 1) joint modeling of costs and effects with two-stage non-parametric bootstrap sampling of clusters then individuals, 2) joint modeling of costs and effects with Bayesian hierarchical models and 3) linear regression of net benefits at different willingness to pay levels using a) least squares regression with Huber-White robust adjustment of errors, b) a least squares hierarchical model and c) a Bayesian hierarchical model. RESULTS: All five methods produced similar results, with greater uncertainty than if cluster randomization was not accounted for. CONCLUSION: Cost effectiveness analyses alongside cluster randomized trials need to account for study design. Several theoretically coherent methods can be implemented with common statistical software. BioMed Central 2007-09-06 /pmc/articles/PMC2020454/ /pubmed/17822546 http://dx.doi.org/10.1186/1478-7547-5-12 Text en Copyright © 2007 Bachmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Bachmann, Max O Fairall, Lara Clark, Allan Mugford, Miranda Methods for analyzing cost effectiveness data from cluster randomized trials |
title | Methods for analyzing cost effectiveness data from cluster randomized trials |
title_full | Methods for analyzing cost effectiveness data from cluster randomized trials |
title_fullStr | Methods for analyzing cost effectiveness data from cluster randomized trials |
title_full_unstemmed | Methods for analyzing cost effectiveness data from cluster randomized trials |
title_short | Methods for analyzing cost effectiveness data from cluster randomized trials |
title_sort | methods for analyzing cost effectiveness data from cluster randomized trials |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020454/ https://www.ncbi.nlm.nih.gov/pubmed/17822546 http://dx.doi.org/10.1186/1478-7547-5-12 |
work_keys_str_mv | AT bachmannmaxo methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials AT fairalllara methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials AT clarkallan methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials AT mugfordmiranda methodsforanalyzingcosteffectivenessdatafromclusterrandomizedtrials |